From there, the dose can continue increasing to 10 mg, 12.5 mg, and ultimately 15 mg if needed and tolerated
This patient with documented PD-L1 expression was treated with the checkpoint inhibitors pembrolizumab, ipilimumab, and nivolumab with pain improvement, but no objective response in disease progression
How does body weight factor into dosing calculations
Since subcutaneous adipocytes typically display lower densities of GH receptors than visceral adipocytes, they may not respond as well to GH-induced or Frag 176-191-mediated lipolysis, possibly resulting in differential regional adipose mobilization
Instead of targeting just one problem, these drugs attack multiple problems simultaneously
doi: 10.1124/jpet.118.254821 63 TonneijckL.MuskietM